STAT Plus: Vertex drug for cystic fibrosis wins approval
The Readout
Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. Here’s our web archive of the free email newsletter delivered daily, Monday through Friday.
Latest
STAT Plus: Is a contrarian leader good for the FDA?
STAT Plus: Biotech stocks hammered after Fed rate projections
STAT Plus: A key decision on compounding is expected this week
STAT Plus: Gameto says first baby born using new stem-cell tech
STAT Plus: Viridian confirms benefit of drug for thyroid eye disease
STAT Plus: GLP-1 drugs spark disagreements in Trump’s circle
STAT Plus: The biotech news you need to read today
All Coverage
